PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease

Download references

Martin Johansson, Lisbeth Ärlestig, Göran Hallmans and Solbritt Rantapää-Dahlqvist^*

* Corresponding author: Solbritt Rantapää-Dahlqvist solbritt.rantapaa.dahlqvist@medicin.umu.se

Arthritis Research & Therapy 2006, 8:R19 doi:10.1186/ar1868

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX